Search

everythinglearnresearchcommunity

for

Search:↓

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Platelet-Rich Fibrin (PRF) can speed up healing in chronic wounds, improve hair density, and act as a natural filler for skin rejuvenation, but its use in hair loss treatment needs more evaluation.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Higher substance P levels may cause discomfort in hair loss patients.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Stress and certain chemicals affect hair growth by interacting with the immune and nervous systems.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

IL-15 promotes hair growth and protects hair follicles.

High mTORC1 activity slows hair growth and causes it to lose color.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Certain sex hormones and antiandrogens can either slow down or speed up the growth of human hair follicle cells depending on their concentration.

The gene URB is more active in human hair growth cells and responds to a hair-related hormone.

Hair follicle stem cells have significant potential for treating various disorders.

Hair loss in men is common, treatable, but not curable.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Removing Lrig1-positive stem cells in mice causes temporary loss of sebaceous glands.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.